Errata by unknown
Urinary Creatinine and Arsenic
Metabolism
Urinary creatinine is almost universally
employed to adjust concentrations of urinary
analytes for variations in hydration status.
In the February 2005 issue of EHP, Barr
et al. used data from the Third National
Health and Nutrition Examination Survey
(NHANES III) to establish reference ranges
for urinary creatinine for specific age and
demographic categories (Barr et al. 2005).
They reported that the significant predic-
tors of urinary creatinine concentrations
include age, sex, race/ethnicity, body mass
index, and fat-free mass. Although these
indicators have been known for many years,
the unintentional adjustment for these
covariates when urinary metabolites are
expressed per gram creatinine can have pro-
found effects on the interpretation of data.
The fact that these effects are often under-
appreciated or even unnoticed renders this
paper highly relevant to exposure assessment
and well worth revisiting. In our studies of
arsenic methylation and one-carbon metabo-
lism, we have noted several additional com-
plications when expressing urinary arsenic as
micrograms per gram creatinine. Note that
one-carbon metabolism refers to the folate-
dependent biochemical pathway responsible
for methylation of DNA, arsenic, and hun-
dreds of other substrates.
Our study in Bangladesh on 1,650 adults
revealed that urinary creatinine concentra-
tions are significantly correlated with plasma
folate concentrations—particularly among
males, who had a higher prevalence of folate
deficiency than females in Bangladesh
(Gamble et al. 2005). Although this associa-
tion had not been previously reported, it is
not surprising considering that the formation
of creatine from methylation of guanidino-
acetate accounts for approximately 75% of
all folate-dependent transmethylation reac-
tions (Mudd and Poole 1975) and that crea-
tine is the direct precursor of creatinine. 
In some analyses, adjusting urinary
arsenic for creatinine obscured correlations
between folate and arsenic metabolism. In
other analyses, correlations between folate
and arsenic/creatinine were due in part to
the associations between folate and creati-
nine. Correct interpretation of the data
would not be possible without considering
the impact of the correlation between uri-
nary creatinine and plasma folate. As did
Barr et al. (2005), we decided to include uri-
nary creatinine in the statistical models as a
separate independent variable. However,
because of the intimate link between crea-
tine metabolism and one-carbon metabo-
lism, inclusion of urinary creatinine in some
models resulted in overcontrolling for the
effects of folate and homocysteine, our vari-
ables of interest. Thus, expression of total
urinary arsenic per gram creatinine runs the
risk of confounding relationships between
total urinary arsenic and arsenic metabolism.
Adjusting for the specific gravity of urine
was not useful because it is so highly corre-
lated with urinary creatinine.
In summary, we concur with Barr et al.
(2005) that urinary creatinine should be
included in multiple regression models as a
separate independent variable; in addition,
the role of one-carbon metabolism as a pre-
dictor of urinary creatinine should also be
considered in interpreting results. Specifically,
we routinely test if urinary creatinine itself is
a predictor of the outcomes of interest.
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Urinary Creatinine: Barr et al.
Respond
Although individual predictors of urinary
creatinine such as sex, body mass index, and
age have been reported, no single research
endeavor has documented the predictors in
one study population as thoroughly as we
reported in our recent article (Barr et al.
2005). The large volume of data available in
the Third National Health and Nutrition
Examination Survey (NHANES III;
1988–1994) [Centers for Disease Control
and Prevention (CDC) 2003a] was ideal for
examining and documenting these predictors.
To date, our study provides the most con-
crete data in the literature demonstrating
creatinine variation in diverse populations
and the factors contributing to this varia-
tion. We agree with Gamble and Liu that
although many research articles have recog-
nized differences in creatinine concentra-
tions within their study populations, few
have attempted to correct for this variation.
Our analysis of urinary creatinine concentra-
tion data in a large, representative segment of
the U.S. population was intended to high-
light the problems that can be encountered
when routinely correcting urinary analyte
concentrations for creatinine; however,
Gamble and Liu point out in their letter yet
another complication that may be encoun-
tered when evaluating urinary concentrations
of chemicals that undergo a folate-mediated
single-carbon metabolism. We are grateful
that they alerted us of the possible complica-
tion of evaluating data for chemicals such as
arsenic. Because folate is routinely measured
in the ongoing NHANES cycles and speci-
ated arsenic measurements have begun in the
same samples, the role of one-carbon metabo-
lism should certainly be considered in inter-
preting results for arsenic and other similarly
metabolized chemicals for future editions of
the CDC’s National Report on Human
Exposure to Environmental Chemicals
(CDC 2001, 2003b).
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Ototoxicity
The January 2005 issue of EHP provided a
much-needed overview of the prevalence of
environment noise and its effects on health
(Chepesiuk 2005; Manuel 2005; Schmidt
2005). Indeed, noise is pervasive and its
adverse health effects are among the most
common occupational injuries. Your consid-
eration of noise-induced damage is especially
welcome, given the strong focus of EHP on
overexposure to chemical agents relative to
overexposure to physical stimuli. Curiously
absent from the discussion, however, was a
review of the evidence that has accumulated
over the past two decades concerning the
ability of chemical agents to produce hearing
impairment directly (ototoxicity) and to
interact with noise exposure yielding either
additive or synergistic impairment of the
auditory apparatus. Research on such
processes has received support in the United
States from multiple agencies, including the
National Institute of Environmental Health
Sciences, the National Institute for Deafness
and Other Communication Disorders, the
National Institute for Occupational Safety
and Health, and the U.S. Environmental
Protection Agency.
Occupational epidemiology studies have
demonstrated noise–chemical interactions in
the workplace, and laboratory animal models
have been effective in identifying oto-
toxicants, establishing dosimetry, identifying
targets of toxicity, and determining the
mechanisms for such ototoxicity. For exam-
ple, occupational epidemiologic studies of
Morata et al. (1997) demonstrated an excess
risk of developing hearing loss among work-
ers exposed to mixed solvents (mainly
toluene) plus noise among printers compared
with noise-exposed referent subjects or non-
exposed matched controls. Similar studies
have subsequently been published for styrene-
exposed workers in the reinforced plastic
industry (Morata et al. 2002; Sliwinska-
Kowalska et al. 2003).
In laboratory animals, the pioneer experi-
ments on the ototoxicity of solvents were ini-
tiated by Pryor and Rebert in the 1980s (e.g.,
Pryor et al. 1987; Rebert et al. 1983). Since
these early studies, the ability of chemicals to
directly disrupt auditory function has been
established for trichloroethylene (Crofton
et al. 1993; Fechter et al. 1998), toluene
(Campo et al. 1999; Crofton et al. 1994;
Johnson 1993), ethyl benzene (Cappaert
et al. 2001), and styrene (Campo et al. 2001),
among other agents. In addition, Lataye et al.
(2001, 2003) have nicely identified the route
by which solvents enter the cochlea and the
pattern of damage that they produce in the
inner ear.
Using developmental models, Rice and
Gilbert (1992) demonstrated that methyl
mercury exposure could impair auditory func-
tion in young primates. Also, hearing impair-
ments have been reported for lead-exposed
children (Osman et al. 1999; Schwartz and
Otto 1987, 1991). Crofton and colleagues
(Crofton et al. 1999, 2000; Lasky et al. 2002)
demonstrated the ability of polychlorinated
biphenyls to disrupt the development of the
cochlea in rats by disrupting thyroid function. 
In this laboratory, we have demonstrated
that a series of chemical contaminants with
potential to disrupt intrinsic antioxidant path-
ways or to enhance reactive oxygen species
(ROS) generation can produce permanent
hearing loss in the presence of noise. These
agents include carbon monoxide (Fechter
et al. 1987, 1988, 2000), hydrogen cyanide
(Fechter et al. 2002), and acrylonitrile
(Fechter et al. 2003; Pouyatos et al. 2005).
This research provided evidence that intense
noise can initiate ROS generation, resulting in
cochlear damage. We hypothesized that even
moderate noise levels, including noise close to
permissible workplace exposure levels, may
initiate ROS formation but that these are nor-
mally contained by antioxidant pathways.
However, in the presence of pro-oxidant
chemical agents, we demonstrated that even
mild noise can yield oxidative stress leading to
the death of sensory receptor cells for sound,
the outer hair cells, and subsequent perma-
nent impairment of auditory function
(Fechter et al. 2000, 2002, 2003; Pouyatos
et al. 2005). It is striking, although not sur-
prising, that the auditory system is vulnerable
to a range of chemical agents that initiate toxic
processes that have been more fully studied in
the brain and other organ systems.
The existing evidence has clear implica-
tions for both environmental and occupa-
tional health, and it highlights the continuing
need for research on the issue. In Europe, the
scientific information available has influ-
enced public health policy. In February
2003, the European Parliament and the
Council of the European Union (2003) pub-
lished Directive 2003/10/EC on minimum
safety requirements regarding the exposure of
workers to noise. Ultimately, an increase in
the awareness of the ototoxic potential of
chemicals should improve preventive efforts
and help reduce the risk of hearing loss.
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Bioremediation Monitoring
In their article published in the February
issue of EHP, Ganey and Boyd (2005) made
some excellent points about the potential pit-
falls of simply assaying for the disappearance
of an environmental pollutant during or as a
result of bioremediation. This is important
because it would be wrong to leave a metabo-
lite that might pose as much or even more
risk then the original chemical of interest.
Ganey and Boyd (2005) used the bio-
remediation of polychlorinated biphenyls
(PCBs) as an example, which was an excel-
lent choice. However, the subject of
metabolism of the PCB bioremediation
metabolites should also be considered. As
chlorines are removed by bioremediation,
the less-chlorinated products could be more
readily metabolized by many species exposed
to the bioremediated material. That is, less-
heavily chlorinated products (or inter-
mediates) of bioremediation may be less
toxic because of shorter half-lives due to
metabolism. This phenomenon can be
exemplified by work we conducted years ago
at Michigan State University. We showed
that 3,4,3´,4´-tetrabromobiphenyl was less
toxic than 3,4,5,3´,4´,5´-hexabromo-
biphenyl, even though it was bound at
higher affinity by the dioxin receptors
because it was more readily metabolized and
eliminated (Millis et al. 1985). 
Commercial preparations contain few or
no strictly coplanar PCB or polybrominated
biphenyl congeners. This fact does not seem
to be appreciated, and the impression is
sometimes given that those very toxic con-
geners are in the environment. In fact, the
coplanar polyhalogenated biphenyls probably
receive way too much attention, most likely
because they were used rather extensively in
research; however, they were used only as
model toxic congeners. The synthesis of
strictly coplanar halogenated biphenyls (i.e.,
3,4,3´,4´-PCB) is much different from that
of the commercial preparations (which was
by simple halogenation of biphenyl). Phenyl
is strongly ortho-para directing, leading to
non-coplanar halogenated biphenyls. The ini-
tial para and/or ortho halogenation makes for
an even stronger ortho-para directive. Thus,
the major components will be non-coplanar
halobiphenyls. Only very small amounts of
single ortho halobiphenyls can be found in
commercial mixtures, and these mixtures are
quite ineffective in eliciting effects associated
with binding by the dioxin receptor. 
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Editor’s note: In accordance with journal
policy, Ganey and Boyd were asked whether
they wanted to respond to this letter, but they
chose not to do so.
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ERRATA
In “Seasick Lungs: How Airborne Algal
Toxins Trigger Asthma Symptoms”
[Environ Health Perspect 113:A324
(2005)], the accompanying photograph
of Karenia brevis should have been cred-
ited to Daniel Baden/University of North
Carolina at Wilmington.
“Linking Toenail Arsenic Content to
Cutaneous Melanoma” [Environ Health
Perspect 113:A377 (2005)] should have
clarified that Laura E. Beane Freeman
received NIEHS funding while at the
University of Iowa, before she joined the
National Cancer Institute.
EHP regrets the errors.
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